In prostate cancer cells, Cnn2 has been reported as an androgen-responsive Srf target gene that affects cell migration (Hossain et al., 2005; Liu and Jin, 2016; Takahashi et al., 1988; Takahashi et al., 1986). Here, SRF is linked to prostate cancer.